Hjem › Steatotisk leversykdom › Florida › Orlando
Kliniske studier for Steatotisk leversykdom i Orlando, FL
9 studier for Steatotisk leversykdom søker deltakere på steder i og rundt Orlando (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
RekruttererFase 3
- 89bio Clinical Study Site, Winter Park · 5 mi unna
- 89bio Clinical Study Site, Ocoee · 10 mi unna
- 89bio Clinical Study Site, Clermont · 24 mi unna
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
RekruttererFase 3
- 89bio Clinical Study Site, Winter Park · 5 mi unna
- 89bio Clinical Study Site, Maitland · 6 mi unna
- 89bio Clinical Study Site, Ocoee · 10 mi unna
- og 1 flere
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
RekruttererFase 2
- Charter Research LLC - Orlando, Orlando
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
RekruttererFase 3
- Charter Research - Orlando, Orlando
- Headlands Research Orlando, Orlando
- K2 Medical Research WINTER GARDEN, Clermont · 24 mi unna
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
RekruttererFase 3
- Akero Clinical Study Site, Orlando
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
RekruttererFase 3
- GSK Investigational Site, Maitland · 6 mi unna
- GSK Investigational Site, Kissimmee · 16 mi unna
- GSK Investigational Site, Clermont · 24 mi unna
Acute Exercise and Endogenous Glucose Production in Type 2 Diabetes: Implications for Glycemic Control and Treatment of Hepatic Steatosis
RekruttererFrivillige helsepersonell ønskes velkommen
- AdventHealth Translational Research Institute, Orlando
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
RekruttererFase 3
- GSK Investigational Site, Maitland · 6 mi unna
- GSK Investigational Site, Kissimmee · 16 mi unna
- GSK Investigational Site, Clermont · 24 mi unna
AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- AdventHealth Translational Research Institute, Orlando
Steatotisk leversykdom-studier i andre byer
- San Antonio, TX17 studier
- New York City, NY16 studier
- Miami, FL16 studier
- San Diego, CA14 studier
- Austin, TX13 studier
- Houston, TX13 studier
- Richmond, VA12 studier
- Tucson, AZ10 studier
- Chandler, AZ10 studier
- Hialeah, FL9 studier
- Dallas, TX9 studier
- St. Louis, MO9 studier
Andre studier i Orlando
- Ikke-småcellet lungekreft44 studier
- Fedme32 studier
- Metastatisk kreft29 studier
- Overvekt27 studier
- Alzheimers sykdom25 studier
- Type 2-diabetes25 studier
- Kreft (alle typer)24 studier
- Brystkreft23 studier
- Eggstokkreft22 studier
- Ulcerøs kolitt22 studier
- Lungekreft21 studier
- Kolorektal kreft19 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.